203 related articles for article (PubMed ID: 33835355)
1. GnRH agonist-associated pituitary apoplexy: a case series and review of the literature.
Guarda FJ; Yu X; Shiraliyeva N; Haines MS; Bradbury M; Saylor PJ; Nachtigall LB
Pituitary; 2021 Oct; 24(5):681-689. PubMed ID: 33835355
[TBL] [Abstract][Full Text] [Related]
2. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
Raj R; Elshimy G; Jacob A; Arya PVA; Unnikrishnan DC; Correa R; Myint ZW
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2337-2347. PubMed ID: 34156518
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy in treatment of prostate cancer: case report and review of literature.
Hands KE; Alvarez A; Bruder JM
Endocr Pract; 2007 Oct; 13(6):642-6. PubMed ID: 17954421
[TBL] [Abstract][Full Text] [Related]
4. Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma.
Sasagawa Y; Tachibana O; Nakagawa A; Koya D; Iizuka H
J Clin Neurosci; 2015 Mar; 22(3):601-3. PubMed ID: 25455737
[TBL] [Abstract][Full Text] [Related]
5. Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case.
Huang TY; Lin JP; Lieu AS; Chen YT; Chen HS; Jang MY; Shen JT; Wu WJ; Huang SP; Juan YS
World J Surg Oncol; 2013 Oct; 11():254. PubMed ID: 24088191
[TBL] [Abstract][Full Text] [Related]
6. Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment.
Barbosa M; Paredes S; Machado MJ; Almeida R; Marques O
Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32554827
[TBL] [Abstract][Full Text] [Related]
7. Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists.
Sinnadurai M; Cherukuri RK; Moses RG; Nasser E
J Clin Neurosci; 2010 Sep; 17(9):1201-3. PubMed ID: 20605467
[TBL] [Abstract][Full Text] [Related]
8. Pituitary apoplexy after leuprolide.
Davis A; Goel S; Picolos M; Wang M; Lavis V
Pituitary; 2006; 9(3):263-5. PubMed ID: 16832587
[TBL] [Abstract][Full Text] [Related]
9. Acute hypopituitarism associated with periorbital swelling and cardiac dysfunction in a patient with pituitary tumor apoplexy: a case report.
Ohara N; Yoneoka Y; Seki Y; Akiyama K; Arita M; Ohashi K; Suzuki K; Takada T
J Med Case Rep; 2017 Aug; 11(1):235. PubMed ID: 28835258
[TBL] [Abstract][Full Text] [Related]
10. Late onset of pituitary apoplexy following gonadotropin-releasing hormone agonist for prostate cancer treatment.
Elshimy G; Raj R; Jacob A; Correa R
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35256375
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration].
Hernandez Morin N; Huet D; Hautecouverture M
Ann Endocrinol (Paris); 2003 Jun; 64(3):227-31. PubMed ID: 12910066
[TBL] [Abstract][Full Text] [Related]
12. Rathke Cleft Cysts with Apoplexy-Like Symptoms: Clinicoradiologic Comparisons with Pituitary Adenomas with Apoplexy.
Jung HN; Kim ST; Kong DS; Suh SI; Ryoo I
World Neurosurg; 2020 Oct; 142():e1-e9. PubMed ID: 32217176
[TBL] [Abstract][Full Text] [Related]
13. Subarachnoid hemorrhage due to pituitary adenoma apoplexy-case report and review of the literature.
Yildiz Y; Lauber A; Char NV; Bozinov O; Neidert MC; Hostettler IC
Neurol Sci; 2024 Mar; 45(3):997-1005. PubMed ID: 37872321
[TBL] [Abstract][Full Text] [Related]
14. Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly.
Dökmetaş HS; Selçuklu A; Colak R; Unlühizarci K; Bayram F; Keleştimur F
J Endocrinol Invest; 1999 Oct; 22(9):698-700. PubMed ID: 10595834
[TBL] [Abstract][Full Text] [Related]
15. Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone.
Masson EA; Atkin SL; Diver M; White MC
Clin Endocrinol (Oxf); 1993 Jan; 38(1):109-10. PubMed ID: 8435878
[TBL] [Abstract][Full Text] [Related]
16. Gestational pituitary apoplexy: Case series and review of the literature.
Jemel M; Kandara H; Riahi M; Gharbi R; Nagi S; Kamoun I
J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):873-881. PubMed ID: 31059861
[TBL] [Abstract][Full Text] [Related]
17. Apoplexy in pituitary macroadenoma: eight patients presenting in 12 months.
Elsässer Imboden PN; De Tribolet N; Lobrinus A; Gaillard RC; Portmann L; Pralong F; Gomez F
Medicine (Baltimore); 2005 May; 84(3):188-196. PubMed ID: 15879908
[TBL] [Abstract][Full Text] [Related]
18. Pituitary Apoplexy Secondary to Gonadotropin-Releasing Hormone Agonist for Breast Cancer.
Mastandrea K; Voica M; Tetlay M; Hasan F
JCEM Case Rep; 2023 May; 1(3):luad069. PubMed ID: 37908581
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus Disease 2019 and Pituitary Apoplexy: A Single-Center Case Series and Review of the Literature.
Martinez-Perez R; Kortz MW; Carroll BW; Duran D; Neill JS; Luzardo GD; Zachariah MA
World Neurosurg; 2021 Aug; 152():e678-e687. PubMed ID: 34129968
[TBL] [Abstract][Full Text] [Related]
20. A Case of Pituitary Apoplexy Following Leuprolide Injection for Prostate Cancer.
Kim KW; Chee S; Sunkara N; Baker MH
R I Med J (2013); 2024 Feb; 107(2):7-9. PubMed ID: 38285742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
